These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 109703)

  • 1. Combined chemoimmunotherapy and radiation therapy of inflammatory breast carcinoma.
    Krutchik AN; Buzdar AU; Blumenschein GR; Hortobagyi GN; Tashima CK; Gutterman JU; Yap HY; Hersh EM
    J Surg Oncol; 1979; 11(4):325-32. PubMed ID: 109703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
    Cancer; 1979 Nov; 44(5):1955-62. PubMed ID: 387212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of locoregionally advanced breast cancer with surgery, radiotherapy, and combination chemoimmunotherapy.
    Hortobagyi GN; Spanos W; Montague ED; Buzdar AU; Yap HY; Blumenschein GR
    Int J Radiat Oncol Biol Phys; 1983 May; 9(5):643-50. PubMed ID: 6343312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of inflammatory carcinoma of breast with combined modality approach - an update.
    Buzdar AU; Montague ED; Barker JL; Hortobagyi GN; Blumenschein GR
    Cancer; 1981 Jun; 47(11):2537-42. PubMed ID: 6790155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-Guérin.
    Hortobagyi GN; Yap HY; Blumenschein GR; Gutterman JU; Buzdar AU; Tashima CK; Hersh EM
    Cancer Treat Rep; 1978 Nov; 62(11):1685-92. PubMed ID: 728894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED).
    Buzdar AU; Blumenschein GR; Smith TL; Tashima CK; Hortobagyi GN; Yap HY; Gutterman JU; Hersh EM; Gehan EA
    J Surg Oncol; 1979; 12(1):27-40. PubMed ID: 480951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined chemoimmunotherapy for advanced breast cancer: a comparison of BCG and levamisole.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Yap HY; Buzdar AU; Tashima CK; Burgess MA; Hersh EM
    Cancer; 1979 Mar; 43(3):1112-22. PubMed ID: 427716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
    Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
    Cancer; 1979 Apr; 43(4):1225-33. PubMed ID: 445325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoimmunotherapy of advanced breast cancer: prolongation of remission and survival with BCG.
    Gutterman JU; Cardenas JO; Blumenschein GR; Hortobagyi G; Burgess MA; Livingston RB; Mavligit GM; Freireich EJ; Gottlieb JA; Hersh EM
    Br Med J; 1976 Nov; 2(6046):1222-5. PubMed ID: 791447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ftorafur, adriamycin, cyclophosphamide and BCG in the treatment of metastatic breast cancer.
    Hortobagyi GN; Blumenschein GR; Tashima CK; Buzdar AU; Burgess MA; Livingston RB; Valdivieso M; Gutterman JU; Hersh EM; Bodey GP
    Cancer; 1979 Aug; 44(2):398-405. PubMed ID: 383255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemoimmunotherapy with FAC-BCG for metastatic breast cancer: the impact of CMF maintenance chemotherapy.
    Hortobagyi GN; Blumenschein GR; Buzdar AU; Yap HY; Schell FC; Barnes BC; Burgess MA
    J Surg Oncol; 1981; 18(2):163-72. PubMed ID: 7300363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancer.
    Buzdar AU; Gutterman JU; Blumenschein GR; Hortobagyi GN; Tashima CK; Smith TL; Hersh EM; Freireich EJ; Gehan EA
    Cancer; 1978 Mar; 41(3):1064-75. PubMed ID: 638948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial chemoimmunotherapy in inflammatory carcinoma of the breast.
    Zylberberg B; Salat-Baroux J; Ravina JH; Dormont D; Amiel JP; Diebold P; Izrael V
    Cancer; 1982 Apr; 49(8):1537-43. PubMed ID: 7066861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.
    Calabresi F; Di Lauro L; Marolla P; Curcio CG; Paoletti G; Calabró A; Giannarelli D; Ballatore P; Foggi CM; Di Palma M
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):66-72. PubMed ID: 2031201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial.
    Buzdar AU; Blumenschein GR; Smith TL; Powell KC; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Ames FC; Martin RG
    Cancer; 1984 Feb; 53(3):384-9. PubMed ID: 6362814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal treatment of locoregionally advanced breast cancer.
    Hortobagyi GN; Blumenschein GR; Spanos W; Montague ED; Buzdar AU; Yap HY; Schell F
    Cancer; 1983 Mar; 51(5):763-8. PubMed ID: 6687377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with irradiation of inflammatory carcinoma of the breast with and without elective chemotherapy.
    Barker JL; Montague ED; Peters LJ
    Cancer; 1980 Feb; 45(4):625-9. PubMed ID: 6766788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
    Aisner J; Weinberg V; Perloff M; Weiss R; Perry M; Korzun A; Ginsberg S; Holland JF
    J Clin Oncol; 1987 Oct; 5(10):1523-33. PubMed ID: 3655855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG.
    Britell JC; Ahmann DL; Bisel HF; Frytak S; Ingle JN; Rubin J; O'Fallon JR
    Cancer Clin Trials; 1979; 2(4):345-50. PubMed ID: 394870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating noncross-resistant combination chemotherapy and active nonspecific immunotherapy with BCG or MER-BCG for advanced breast carcinoma.
    Blumenschein GR; Hortobagyi GN; Richman SP; Gutterman JU; Tashima CK; Buzdar AU; Burgess MA; Livingston RB; Hersh EM
    Cancer; 1980 Feb; 45(4):742-9. PubMed ID: 6986970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.